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Abstract
Retroviral Gag polyproteins are necessary and sufficient for virus budding. Productive HIV-1 Gag assembly takes place at the
plasma membrane. However, little is known about the mechanisms by which thousands of Gag molecules are targeted to
the plasma membrane. Using a bimolecular fluorescence complementation (BiFC) assay, we recently reported that the
cellular sites and efficiency of HIV-1 Gag assembly depend on the precise pathway of Gag mRNA export from the nucleus,
known to be mediated by Rev. Here we describe an assembly deficiency in human cells for HIV Gag whose expression
depends on hepatitis B virus (HBV) post-transcriptional regulatory element (PRE) mediated-mRNA nuclear export. PRE-
dependent HIV Gag expressed well in human cells, but assembled with slower kinetics, accumulated intracellularly, and
failed to associate with a lipid raft compartment where the wild-type Rev-dependent HIV-1 Gag efficiently assembles.
Surprisingly, assembly and budding of PRE-dependent HIV Gag in human cells could be rescued in trans by co-expression of
Rev-dependent Gag that provides correct membrane targeting signals, or in cis by replacing HIV matrix (MA) with other
membrane targeting domains. Taken together, our results demonstrate deficient membrane targeting of PRE-dependent
HIV-1 Gag and suggest that HIV MA function is regulated by the trafficking pathway of the encoding mRNA.
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Introduction
Retrovirus assembly and budding is a highly concerted process
mediated by largely undefined spatially- and temporally-regulated
interactions between viral proteins and cellular factors. During the
viral assembly process, thousands of copies of viral structural
polyproteins multimerize to form virus particles via an energy-
dependent, multi-step process. Expression of retroviral Gag
polyprotein is generally sufficient for the assembly and release of
non-infectious virus like particles (VLPs). The Gag polyprotein
consists of matrix (MA), capsid (CA), nucleocapsid (NC), late
domain, and spacer proteins and is cleaved into the distinct
structural proteins upon virus maturation [1,2]. These Gag
domains orchestrate the major steps in virus assembly and
budding (reviews [1,2]). It is well established that HIV-1 Gag
buds from the plasma membrane of T lymphocytes and some
epithelial cell lines [1–5]. In contrast, the major histocompatibility
complex (MHC) class II compartments or multivesicular bodies
(MVBs) are apparently the sites of HIV-1 Gag accumulation and
particle production in macrophages and dendritic cells [6–9].
However, recent studies indicate that in macrophage HIV-1
virions bud from invaginated plasma membranes [10,11]. Little is
known about the precise mechanisms by which thousands of
copies of Gag molecules synthesized from ribosomes in the
cytoplasm are transported to specific locations on the plasma
membrane for assembly and budding. Consistent with results
published by Malim and colleagues [12,13], our recent work
suggests that HIV-1 Gag assembly is regulated at a step as early as
nuclear export of its encoding mRNA [14].
Retroviral Gag polyproteins are synthesized from an unspliced
full-length viral genomic mRNA that requires specific regulatory
factors for nuclear export. The HIV-1 genome contains a cis-
acting RNA element known as the Rev-response element (RRE)
that binds to a viral trans-acting protein (Rev). Rev binds to the
nuclear export protein Crm1 which in turn binds to Ran, a small
GTPase that shuttles between the nucleus and the cytoplasm.
Some simple retroviruses, such as Mason-Pfizer monkey virus (M-
PMV), contain cis-acting RNA export elements (constitutive
transport elements or CTE) that do not require viral trans-acting
factors and that function by interacting directly with cellular
export factors NXF1/NXT [13]. Swanson et al [12] recently
demonstrated that altering the RNA nuclear export element used
by HIV-1 gag-pol mRNA from the RRE to the CTE resulted in
efficient trafficking and assembly of Gag at cellular membranes in
murine cells, which are notable for their inability to support HIV-1
assembly and budding [12,15,16]. Our recent study also
demonstrated that one copy of the hepatitis B virus posttranscrip-
tional regulatory element (PRE) could support a similar level of
HIV-1 Gag expression compared with Rev-dependent Gag [14]
and that HIV-1 Gag assembly and budding in mouse cells could
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be rescued by substitution of the Rev-dependent RNA nuclear
export signal with PRE [14]. Interestingly, in human cells the
PRE-dependent, Rev-independent HIV-1 Gag showed lower
assembly efficiency and different assembly sites compared with
Rev-dependent HIV-1 Gag [14]. These results support the model
that RNA export pathway selection during Gag expression and
assembly can affect the cytosolic fate or function of the HIV-1 Gag
polyproteins. In the current study, we sought to define the
determinants of inhibited PRE-dependent HIV-1 Gag assembly
and budding in human cells and to test whether altering these
determinants can alleviate this block.
Results
Distinct Intracellular Distribution and Assembly Kinetics
of Rev-dependent and PRE-dependent HIV-1 Gag
We recently demonstrated different assembly efficiencies and
assembly sites for Rev-dependent and PRE-dependent HIV-1 Gag
in both human and mouse cell lines [14]. We proposed that the
observed distinct Gag assembly patterns could be the result of
differential intracellular Gag trafficking as a consequence of the
different pathways used for the export of HIV-1 Gag mRNA from
the nucleus. Since the BiFC assays used in our previous study only
revealed assembled Gag multimers inside cells, in the current study
we first visualized the distribution of the total population of Rev-
dependent or PRE-dependent HIV-1 Gag-GFP in 293T cells over
time using live cell imaging. The results of these studies revealed
that Rev-dependent HIV-1 Gag-GFP quickly (,1 hr) assembled
into bright puncta on cell surface after appearance of the GFP
signal (Fig. 1A and supplemental Video S1). In marked contrast,
PRE-dependent HIV-1 Gag-GFP was diffusely distributed
throughout the cells over a long time course (.10 hr), and did
not form bright puncta on the cell surface even though large
amounts of Gag-GFP were synthesized (Fig. 1B and supplemental
Video S2). If the punctate Gag-GFP signal represents assembled
Gag multimers as previously suggested [17], our results indicate
faster assembly kinetics of Rev-dependent HIV-1 Gag compared
with PRE-dependent HIV-1 Gag.
Recent reports indicate that the efficiency of retrovirus assembly
depends on the concentration of Gag molecules [18]. To test if the
observed delayed assembly of PRE-dependent HIV-1 Gag could be
attributed to a lower expression level compared with Rev-dependent
HIV-1 Gag, the expression and trafficking of Gag-GFP in individual
cells was monitored by live cell imaging after transfection with either
Rev-dependent or PRE-dependent HIV-1 Gag-GFP. For these
assays, 30 cells from each transfection were randomly selected and
analyzed individually, as summarized in Figure 2. These data reveal
marked differences in the expression kinetics and trafficking patterns
of the Gag-GFP produced by Rev-dependent or PRE-dependent
expression. Both the Rev-dependent HIV-1 Gag-GFP expressing
cells (black diamond) and the PRE-dependent HIV-1 Gag-GFP
expressing cells (gray square) showed an increase of fluorescence
over time (Figure 2A). However, the mean fluorescence intensity of
PRE-dependent HIV-1 Gag-GFP expressing cells is consistently
higher than Rev-dependent HIV-1 Gag-GFP expressing cells at all
time points, with a 5-fold higher expression being observed at
9 hours after the initial detection of Gag-GFP expression. All the 30
randomly chosen Rev-dependent HIV-1 Gag-GFP expressing cells
started to form bright puncta at surface at early time point (average
44 minutes after Gag-GFP started to be detected) with the average
mean fluorescence intensity of 17 (Figure 2B), indicating a fast
assembly kinetic of Rev-dependent HIV-1 Gag upon protein
synthesis. In marked contrast, among the 30 randomly chosen PRE-
dependent HIV-1 Gag-GFP expressing cells, only 7 cells displayed
bright puncta at very late time points with the average mean
fluorescence intensity of 1079 (Figure 2B). Taken together, this
single cell imaging assay demonstrates that PRE-dependent Gag
was in fact synthesized with similar kinetics and to similar
concentrations as Rev-dependent Gag. However, the observations
clearly indicated that the PRE-dependent Gag displayed a distinct
trafficking pattern in transfected cells compared to the Rev-
dependent Gag and failed to assemble into VLP as efficiently that
leaded to intracellular Gag accumulation. Thus, these data support
the concept that Gag assembly may be significantly influenced by
the nuclear export pathway of its mRNA.
Having established similar expression levels in cells transfected
with Rev-dependent or PRE-dependent Gag constructs, we next
sought to compare the extracellular VLP production between cells
transfected with either the Rev-dependent or PRE-dependent
HIV-1 Gag. For these assays 293T cells were transfected with
either HA-tagged PRE-dependent or Rev-dependent HIV-1 Gag
expression plasmids. A G2A Gag mutant that lacks myristoylation
and fails to bind to membranes for assembly was used as a
reference for a budding deficient Gag [2]. Cells were transfected in
parallel with Rev-dependent or PRE-dependent Gag, or with G2A
mutant HIV-1 Gag expression plasmids. At 24 h post transfection,
cell lysates and supernatant pellets (VLPs) were subjected to SDS-
PAGE and Western Blotting to determine the respective Gag
budding efficiencies (Figure 2C). The results indicate essentially
undetectable levels of VLP budding from cells transfected with the
PRE-dependent HIV-1 Gag, as observed with the myristoylation
deficient G2A mutant Gag (Figure 2C, lines 3–5). In distinct
contrast, a high level of extracellular VLP was produced from cells
transfected with the Rev-dependent HIV-1 Gag, reflecting
efficient assembly and budding by protein produced from this
construct (Figure 2C, lines 1 and 2). Interestingly, analyses of the
transfected cellular lysates indicated similar levels of intracellular
Gag accumulation in cells transfected with any of the three
assembly deficient Gag constructs, evidently reflecting similar
levels of Gag expression regardless of the specific Gag construct
(Figure 2C, compare line 3–5 and lines 1). Take together, these
data are consistent with our previous report that Rev-dependent
HIV-1 Gag assembles more efficiently in human cells compared
with PRE-dependent HIV-1 Gag [14], despite the similar levels of
Gag expression observed for the respective expression plasmids.
Co-assembly of Rev-dependent and PRE-dependent HIV-
1 Gag Rescues Budding of PRE-dependent HIV-1 Gag
We next took advantage of the BiFC assay to test whether Rev-
dependent and PRE-dependent HIV-1 Gag can interact with each
other even though they may utilize different trafficking pathways.
Co-expression of Rev-dependent Gag-VC with PRE-dependent
Gag-VN (Fig. 3B, panel c) or of Rev-dependent Gag-VN with
PRE-dependent Gag-VC (Fig. 3B, panel d) both resulted in bright
punctate BiFC signals on the plasma membrane, indicating
interactions between Rev-dependent and PRE-dependent HIV-1
Gag. This pattern was similar to the BiFC pattern obtained upon
coexpression of Rev-dependent HIV-1 Gag VN and VC pairs
(Fig. 3B, panel a). In marked contrast, expression of PRE-
dependent HIV-1 Gag VN and VC pairs resulted in a weaker
intracellular punctate signal above a diffuse background (Fig. 3B,
panel b), as we reported previously [14].
Since Rev-dependent HIV-1 Gag could efficiently co-assemble
with PRE-dependent Gag at the plasma membrane, we next tested
whether this co-assembly can rescue PRE-dependent HIV-1 Gag
budding in human cells (Fig. 4B). PRE-dependent HIV-1 Gag-
GFP was co-transfected with empty vector, HA-tagged PRE-
dependent, or Rev-dependent HIV-1 Gag in 293T cells. At 24 h
HIV-1 Gag Assembly
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post transfection, cell lysates and supernatant pellets (VLPs) were
subjected to SDS-PAGE and Western Blotting to determine
budding efficiencies. Co-expression with Rev-dependent HIV-1
Gag-HA enhanced PRE-dependent HIV-1 Gag-GFP budding by
about 30 fold (Fig. 4B, compare lanes 1 and 3). In contrast, this
enhancement was not observed upon co-expression of PRE-
dependent HIV-1 Gag-HA (Fig. 4B, compare lanes 1 and 2).
To gain further insight into the key determinants in Rev-
dependent Gag required to restore budding of co-expressed Rev-
independent Gag, we generated a panel of Rev-dependent HIV-1
Gag mutants (Fig. 4A) and tested their ability to rescue PRE-
dependent HIV-1 Gag-GFP budding (Fig. 4B). A mutant with a
constitutively exposed myristol residue generated by replacing MA
with the myristoylation signal of v-Src (SrcDMA) [19–21] (Fig. 4B,
Figure 1. Distinct intracellular distribution and assembly dynamics of Rev-dependent and PRE-dependent HIV-1 Gag. 293T cells were
transfected with Rev-dependent (A) and PRE-dependent (B) HIV-1 Gag-GFP and monitored with time-lapse confocal microscopy. Images of different
Z sections were overlaid to produce single extended-focus image for each time point. Arrays of individual frames from two time-lapse videos
covering about 12 hr compare the distribution and assembly dynamics of Rev-dependent and PRE-dependent HIV-1 Gag.
doi:10.1371/journal.pone.0006551.g001
HIV-1 Gag Assembly
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lane 4) could rescue budding of co-expressed PRE-dependent
HIV-1 Gag-GFP as efficiently as wild type Rev-dependent HIV-1
Gag (Fig. 4B, lane 3). However, the myristoylation deficient G2A
mutant (Fig. 4B, lane 5) and CA deletion mutant (DCA) (Fig. 4B,
lane 6) were unable to enhance budding of co-expressed PRE-
dependent HIV-1 Gag-GFP compared to co-expression of Rev-
dependent wild type HIV-1 Gag (Fig. 4B, lane 2). Together, these
results indicate that proper membrane association of Rev-
dependent HIV-1 Gag constructs and co-assembly of Rev-
dependent Gag with PRE-dependent Gag are required to rescue
the budding of PRE-dependent HIV-1 Gag in human cells.
Substitution of the Membrane Binding Domain Rescues
PRE-dependent HIV-1 Gag Assembly and Budding
Because our results suggested that membrane targeting of Rev-
dependent HIV-1 Gag is required to rescue budding of co-
assembled PRE-dependent HIV-1 Gag, we next asked whether
PRE-dependent HIV-1 Gag assembly and budding in human cells
can be rescued by substitution of the HIV-1 membrane binding
motif with other membrane targeting motifs. We have previously
reported that in contrast to HIV-1 Gag, both Rev-dependent and
PRE-dependent EIAV Gag can efficiently assemble and bud from
human cells [14]. Thus, we also tested whether switching MA
domains of EIAV and HIV-1 Gag altered their respective
assembly and budding phenotypes.
We first constructed a panel of PRE-dependent HIV-1 Gag and
EIAV Gag MA mutants (Fig. 5A). 293T cells were transfected with
this panel of HA tagged PRE-dependent HIV-1 Gag and EIAV
Gag constructs, followed by Western blotting of cell lysates and
pelleted VLPs at 24 h post transfection. Replacing the HIV MA
with the v-Src myristoylation signal rescued PRE-dependent HIV-1
Gag budding (Fig. 5B, compare lane 1 and lane 2). Consistent with
Figure 2. Deficient assembly and budding of PRE-dependent HIV-1 Gag. (A) Comparison of mean fluorescence intensity of 293T cells
transfected with Rev-dependent (black diamond) or PRE-dependent HIV-1 Gag-GFP (gray square). Ceslls were monitored with time-lapse confocal
microscopy as described in Figure 1. 30 randomly selected cells for each were tracked immediately after GFP fluorescence appeared and mean
fluorescence intensity was measured. Average mean fluorescence intensity was plot over time. (B) Comparison of mean fluorescence intensity of
293T cells transfected with Rev-dependent (black diamond) or PRE-dependent HIV-1 Gag-GFP (gray square) when Gag-GFP puncta appear. All the 30
Rev-dependent HIV-1 Gag-GFP transfected cells tracked in (A) and 7 of the 30 PRE-dependent HIV-1 Gag-GFP transfected cells tracked in (A) displayed
Gag-GFP puncta. (C) Budding of Rev-dependent and PRE-dependent wild type and myristoylation mutant HIV-1 Gag-HA. Rev-dependent and PRE-
dependent Gag constructs were transfected into 293T cells. At 24 h post transfection, VLPs (upper panel) were analyzed by immunoblotting using HA
antibody and cell lysates (lower panel) were analyzed by immunoblotting using HA and actin antibody. Data are representative of three independent
experiments.
doi:10.1371/journal.pone.0006551.g002
HIV-1 Gag Assembly
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our previous observations [14], and in contrast to PRE-dependent
HIV-1 Gag, PRE-dependent EIAV Gag could bud efficiently from
human cells (Fig. 5B, compare lane 1 and lane 4). Interestingly, MA
swapping reversed this phenotype. PRE-dependent chimeric HIV-1
Gag containing EIAV MA budded as efficiently as PRE-dependent
EIAV Gag (Fig. 5B, compare lane 3 and lane 5), whereas PRE-
dependent chimeric EIAV Gag containing HIV MA failed to bud
efficiently (Fig. 5B, lane 6). The PRE-dependent chimeric EIAV
Gag budding deficiency seemed to be specific for the HIV MA,
because replacing EIAV MA with the v-Src myristoylation signal
did not interfere with chimeric EIAVGag budding (Fig. 5B, lane 5).
Distinct Membrane Association Properties of Rev-
dependent and PRE-dependent HIV-1 Gag
Our live cell imaging results revealed an apparent cytoplasmic
accumulation of PRE-dependent HIV-1 Gag over time. Addi-
tionally, the budding rescue assays described above suggested that
MA-dependent membrane targeting of PRE-dependent HIV-1
Gag was apparently deficient in human cells. These observations
led us to test whether the membrane association properties of
PRE-dependent HIV-1 Gag are different from Rev-dependent
HIV-1 Gag (Fig. 6). Postnuclear supernatants derived from 293T
cells expressing either Rev-dependent HIV-1 Gag or PRE-
dependent HIV-1 Gag were analyzed using membrane flotation
to segregate membrane-associated and soluble Gag [22,23]. After
centrifugation, gradient fractions were collected and analyzed for
Gag content by Western blotting. Transferrin receptor and actin
were used as markers for membrane (fractions 1 to 3) and soluble
(fractions 7 to 9) fractions, respectively. Roughly equal amounts of
Rev-dependent (,60%) and PRE-dependent (,50%) HIV-1 Gag
were recovered in membrane fractions, and these populations
represented a significant proportion of the total Gag expressed in
each case (Fig. 6A and 6C). Under the same conditions,
myristoylation deficient G2A mutants were not present in
membrane fractions regardless of whether they were expressed
in a Rev-dependent or PRE-dependent context, consistent with
previous reports [23–25]. These data suggest that PRE-dependent
HIV-1 Gag can target human cell membranes and is unlikely to be
myristoylation deficient, consistent with other studies showing
efficient membrane association of other Rev-independent HIV-1
Gag in human cells [25–27]. Taken together with the fluorescence
microscopy results (Fig. 1), our data suggest that unlike Rev-
dependent HIV-1 Gag, PRE-dependent HIV-1 Gag fails to
specifically bind to plasma membrane. Cytosolic soluble Gag and
random membrane bound Gag together display a diffusive
distribution pattern of PRE-dependent Gag in human cells.
Figure 3. Co-assembly of Rev-dependent HIV-1 Gag and PRE-dependent HIV-1 Gag. (A) Schematic diagram of plasmids expressing Rev-
dependent and PRE-dependent HIV-1 Gag-BiFC constructs. (B) Demonstration of co-assembly of Rev-dependent and PRE-dependent HIV-1 Gag by
BiFC. HeLa cells grown on glass coverslips were transfected with plasmids expressing the indicated HIV-1 Gag-BiFC pair. At 8 h post transfection, cells
were fixed and imaged. Bar: 10 mm.
doi:10.1371/journal.pone.0006551.g003
HIV-1 Gag Assembly
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It has been reported that plasma membrane lipid rafts play a
critical role in HIV-1 Gag assembly and budding [28–33]. Raft
association of HIV-1 Gag occurs after membrane binding [31] and
is independent of the Gag assembly ability [30,31]. Therefore we
next tested whether Rev-dependent and PRE-dependent HIV-1
Gag were differentially targeted to lipid rafts (Fig. 6B). Postnuclear
supernatants derived from 293T cells expressing either Rev-
dependent HIV-1 Gag or PRE-dependent HIV-1 Gag were
analyzed as described above except that they were treated with
0.5% Triton X-100 on ice for 30 min before being subjected to
membrane flotation. Under these conditions, transferrin receptor, a
membrane protein known not to partition into detergent-insoluble
microdomains, was not detected in lipid raft fractions. About one
third of the membrane-associated Rev-dependent HIV-1 Gag could
still be detected in these fractions after cold Triton X-100 treatment,
demonstrating its association with lipid rafts or detergent-resistant
membranes (Fig. 6C, left panel). In contrast, only 6% of the
membrane-associated Rev-independent HIV-1 Gag was present in
Figure 4. Coexpression of membrane targeting and assembly competent Rev-dependent HIV-1 Gag rescues PRE-dependent HIV-1
Gag budding. (A) Schematic diagram of plasmids expressing HA tagged Rev-dependent HIV-1 Gag mutants. (B) Budding of PRE-dependent HIV-1
Gag-GFP upon co-expression with PRE-dependent or Rev-dependent HIV-1 Gag-HA. PRE-dependent HIV-1 Gag-GFP was co-transfected at an equal
molar ratio into 293T cells with empty vector, PRE-dependent HIV-1 Gag-HA, or the indicated Rev-dependent HIV-1 Gag-HA constructs described in A.
At 24 h post transfection, VLPs (upper panel) and cell lysates (lower panel) were analyzed by immunoblotting using GFP and HA antibody. Data are
representative of three independent experiments.
doi:10.1371/journal.pone.0006551.g004
HIV-1 Gag Assembly
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lipid raft-containing fractions after detergent extraction (Fig. 6C,
right panel).
Discussion
Recently, we reported that HIV-1 Gag assembly and budding
are regulated by the nuclear export pathway of Gag-encoding
mRNA [14]. PRE-dependent HIV-1 Gag was trafficked differ-
ently as compared to native Rev-dependent Gag resulting in a
defect in Gag assembly and budding in human cells [14]. In the
current study, we performed a mechanistic analysis of the
regulation of HIV-1 Gag assembly and budding by mRNA
nuclear export pathways. We demonstrate that PRE-dependent
HIV-1 Gag is mistargeted in human cells, evidently because the
Gag produced by PRE-dependent expression lacks the membrane
raft targeting function of HIV MA. This finding is reminiscent of
deficient Rev-dependent HIV-1 Gag assembly/budding in mouse
cells resulting from deficient MA dependent membrane targeting
[12,26,34]. As such, the current data supports the concept that
Figure 5. Substitution of HIV-1 matrix with other membrane targeting domains rescued PRE-dependent HIV-1 Gag budding in
human cells. (A) Schematic diagram of plasmids expressing HA tagged PRE-dependent HIV-1 Gag mutants (upper panel) and EIAV Gag mutants
(lower panel). (B) Budding of PRE-dependent HIV-1 and EIAV Gag mutants. 293T cells were transfected with the indicated PRE-dependent HIV-1 and
EIAV Gag mutants described in (A). At 24 h post transfection, VLPs (upper panel) and cell lysates (lower panel) were analyzed by immunoblotting
using HA antibody. Data are representative of three independent experiments.
doi:10.1371/journal.pone.0006551.g005
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Figure 6. PRE-dependent HIV-1 Gag failed to associate with lipid raft in human cells. (A) Both Rev-dependent and PRE-dependent HIV-1
Gag are membrane-associated in human cells. Postnuclear supernatants derived from 293T cells expressing Rev-dependent or PRE-dependent HIV-1
Gag, Rev-dependent or PRE-dependent G2A mutant were subjected to equilibrium flotation centrifugation. Pr55Gag, TfR and actin were detected by
Western blotting. Membrane- and non-membrane-associated fractions were shown. (B) Rev-dependent HIV-1 Gag but not PRE-dependent HIV-1 Gag
is associated with Triton X-100 insoluble lipid rafts in human cells. Postnuclear supernatants derived from 293T cells expressing Rev-dependent or
PRE-dependent HIV-1 Gag were treated with 0.5% Triton X-100 on ice for 30 min prior to membrane flotation analysis. Pr55Gag, TfR and actin were
detected by Western blotting. Raft and non-raft fractions are indicated. (C) Quantitation of Rev-dependent (left panel) and PRE-dependent (right
panel) HIV-1 Gag in each fraction with (open circles) or without (closed squares) cold Triton extraction.
doi:10.1371/journal.pone.0006551.g006
HIV-1 Gag Assembly
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MA-directed membrane targeting and assembly of Gag is
dependent on the pathway used for trafficking of the Gag mRNA.
It is thought that the primary function of the MA domain in
retrovirus assembly is to mediate membrane association of Gag
polyprotein. The three-dimensional structure of HIV-1 MA reveals
a globular head conformation [35,36]. The N-terminal myristic acid
and the highly basic patch formed by conserved positive charged
residues clustered on the surface of the MA globular head both
contribute to HIV-1 MA dependent membrane binding of Gag
precursors [37]. Structural studies demonstrate specific binding
interactions between myristoylated HIV-1 MA and phosphatidyli-
nositol-(4,5)-bisphosphate [PI(4,5)P2], which triggers a change in
protein conformation that flips myristate from the sequestered to the
exposed conformation, thereby promoting the stable association of
MA with the membrane [20]. Previous intracellular functional
studies also demonstrate that PI(4,5)P2 plays a key role in Gag
targeting to the plasma membrane [4] and the recent lipid analysis
of HIV-1 virions demonstrated a MA-dependent enrichment of
PI(4,5)P2 in viral lipid envelope [28]. It has been suggested that
PI(4,5)P2 may preferentially associate with lipid rafts [38,39].
Therefore the PI(4,5)P2 induced myristoyl switch could regulate
lateral targeting of PI(4,5)P2:Gag complexes to lipid rafts that play a
critical role in HIV-1 assembly and budding [31–33,40]. In addition
to lipid, HIV-1 MA also binds to RNA through its basic residues
[41,42]. Therefore it can be speculated that RNA binding might
place another layer of regulation on MA dependent membrane
targeting, possibly by regulating the PI(4,5)P2-induced myristoyl
switch of HIV-1 MA.
Our data suggest that HIV MA in the context of PRE-
dependent Gag causes unspecific membrane targeting. Promiscu-
ous membrane binding would prevent Gag association with
plasma membrane lipid rafts that support Gag assembly. Our
current studies do not address the detailed molecular mechanism
behind the mistargeting of PRE-dependent HIV-1 Gag in human
cells. At this time, we can only speculate as to how RNA export
pathways affect the membrane targeting function of HIV-1 MA.
We hypothesize that HIV MA mediated plasma membrane
rafts targeting is tightly regulated both temporally and spatially
and relies on the sequential acquisition and release of host factors.
In human cells, PRE-dependent Gag may exhibit a defect in the
PI(4,5)P2 regulated myristoyl switch that could be due to the
inability to associate with specific cellular cofactors (RNA or
proteins). This defect can be rescued by in trans by Rev-dependent
wild type HIV-1 Gag but not by myristoylation deficient G2A or
multimerization deficient DCA mutants. Importantly, the defi-
ciency of PRE-dependent HIV-1 Gag can also be rescued in cis by
replacing MA with other membrane targeting motifs, suggesting
that efficient membrane targeting by HIV MA requires Rev-
dependent trafficking. In the absence of Rev-dependent traffick-
ing, MA exhibits an inhibitory effect on Gag assembly. Retroviral
genomic RNA (gRNA) serves as the mRNA template for Gag
synthesis as well as the genetic component of infectious viruses. In
our studies, the PRE-dependent HIV-1 Gag was expressed from a
mRNA encoding no viral accessory proteins and containing no
gRNA sequence. We believe that it is unlikely that the deficiency
of PRE-dependent HIV-1 Gag would only be due to the lack of
these viral factors, because membrane binding (G2A) and
multimerization deficient (DCA) Rev-dependent Gag constructs
failed to rescue PRE-dependent Gag assembly and budding,
despite expressing all accessory proteins. In addition, although
gRNA provides the scaffold for Gag assembly, this function can be
replaced by cellular tRNA and rRNA [43].
Various studies in cell biology have demonstrated that specific
RNA localization is a widely used mechanism affecting protein
function at multiple levels [44]. For example, ,70% of mRNAs in
oocytes and early embryos of Drosophila are localized in dozens of
distinct patterns [45]. Considerable evidence suggests that retroviral
Gag trafficking and assembly/budding is regulated by both nuclear
export [12–14,46] and cytoplasmic transport [22,47] of viral gRNA.
Our results comparing trafficking and assembly of HIV-1 Gag
expressed from mRNA using Rev-dependent (Crm 1 dependent)
[48] and PRE-dependent (Crm 1 independent) [49] nuclear export
pathways provide further support for this idea. At this point, we do
not know whether localized Gag synthesis plays a role in plasma
membrane targeting or if Gag synthesized from RNA takes different
trafficking routes. Clearly, the current data argue that RNA
trafficking also regulates protein function during retrovirus assem-
bly. In closing, PRE-dependent HIV-1 Gag exhibits an MA-
dependent assembly defect in human cells. Together with assembly
deficient Rev-dependent HIV-1 Gag in mouse cells, this model can
provide a valuable tool to study how HIV assembly is temporally
and spatially regulated and coordinated with genome packing.
Materials and Methods
DNA mutagenesis
Overlapping PCR was used to construct Gag mutations and
fusion proteins. Rev-dependent and Rev-independent HIV-1
(pNL4–3 proviral clone [50]) and EIAV (pEIAVuk proviral clone
[51]) Gag expression vectors were described previously [14].
Briefly, the hepatitis B virus posttranscriptional regulatory element
(PRE) was attached to the C-terminus of EIAV or HIV-1 Gag
gene to generate Rev-independent EIAV or HIV-1 Gag
expression vectors. Rev-dependent EIAV or HIV-1 Gag con-
structs were made based on pEIAVuk or pNL4–3 proviral
constructs. For BiFC assays, gene sequences encoding the amino
(residues 1–173, VN)- or carboxyl (residues 155–238, VC)-
fragments of Venus fluorescence protein were fused to the C-
terminus of EIAV or HIV-1 Gag via a 6-alanine linker as
described previously [14]. To make hemagglutinin (HA) epitope-
tagged Gag polyproteins, the YPYDVPDYA epitope from
influenza virus HA protein was inserted into the C-terminus of
p9 or p6 protein, respectively. All plasmids were isolated using the
Qiagen Midiprep Kit (Qiagen, Valencia, CA), and the specific
mutations were confirmed by DNA sequencing.
Cell culture and transfection
HeLa SS6 and 293T cells were cultured in Dulbecco’s Modified
Essential Medium (DMEM) supplemented with 10% fetal bovine
serum (Invitrogen, Carlsbad, CA). Cells were transfected using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) following the
procedures outlined by the manufacturer.
Gag budding assays
At 24 h post transfection, cells were harvested and lysed in lysis
buffer (25 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% deoxycholic
acid, 1% Triton X-100, 16 protease inhibitor cocktail) and
centrifuged at 20,8006g for 5 min to remove cell nuclei. Virus-like
particles (VLPs) released into the culture medium were pelleted by
centrifugation (20,8006g for 3 h at 4uC) and resuspended in PBS.
HA-Gag contained in cell lysates and VLPs was analyzed by
Western Blotting using rat anti-HA antibody (Roche Applied
Science, Indianapolis, IN) and HRP conjugated goat anti-rat IgG
(Invitrogen, Carlsbad, CA), as described previously [14].
Membrane flotation analysis
Membrane flotation procedures were performed as described
[22,23]. At 24 h post-transfection, 293T cells were washed twice
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with phosphate-buffered saline, collected, and homogenized in
300 ml of TE buffer (10 mM Tris [pH 7.4], 1 mM EDTA [pH 8])
containing 10% sucrose and protease inhibitor cocktail by
passaging 24 times through a 23G11/4 needle. Nuclei were
removed by centrifugation at 1,0006g. A 250 ml sample of post
nuclear supernatant (PNS) was mixed with 1.25 ml of TE 85.5%
sucrose (adjusting the concentration of sucrose to 73%) and
deposited at the bottom of a 5-ml centrifugation tube. TE 65%
sucrose (2.5 ml) and then 1 ml of TE 10% sucrose were layered
above the lysate. The samples were subjected to ultracentrifuga-
tion at 100,0006g for at least 14 h at 4uC in a SW55Ti rotor
(Beckman Coulter). To determine lipid raft association, PNSs were
treated with Triton X-100 (final concentration 0.5%) for 30 min
on ice prior to flotation centrifugation. Nine fractions of 550 ml
were collected from the top and analyzed by Western Blotting
using the rat monoclonal anti-HA antibody (Roche Applied
Science, Indianapolis, IN), mouse monoclonal anti-human trans-
ferrin receptor antibody (Invitrogen, Carlsbad, CA) and mouse
monoclonal anti-bactin antibody (Sigma-Aldrich, Saint Louis,
MO). X-ray films were scanned and analyzed by the ImageJ
1.386 software (http://rsb.info.nih.gov/ij/).
Imaging
For BiFC assays, transfected cells grown on coverslips were fixed
and permeabilized with 2% paraformaldehyde and 0.1% Triton X-
100 in PBS. Images were captured using a Leica TCS-SL
microscope and processed with Metamorph software. For live cell
imaging, cells were plated on 35-mm imaging dishes (MatTek,
Ashland, MA) and transfected with GFP tagged HIVGag expression
vector. At 8 hr post transfection, images were captured every 20 min
using a Nikon TE2000E spinning disc confocal microscope. Single
cell tracking was performed using Volocity software tracking module
(Improvision, Lexington, MA). All time-lapse movies were edited
using Volocity software (Improvision, Lexington, MA).
Supporting Information
Video S1 Intracellular distribution and assembly dynamics of
Rev-dependent HIV-1 Gag. 293T cells were transfected with Rev-
dependent HIV-1 Gag-GFP and monitored with time-lapse
confocal microscopy from 6 hour post transfection. Three
dimensional images were taken every 20 minutes. For each time
point, images of different Z sections were overlaid to produce
single extended-focus image.
Found at: doi:10.1371/journal.pone.0006551.s001 (4.95 MB
MOV)
Video S2 Intracellular distribution and assembly dynamics of
PRE-dependent HIV-1 Gag. 293T cells were transfected with
PRE-dependent HIV-1 Gag-GFP and monitored with time-lapse
confocal microscopy from 6 hour post transfection. Three
dimensional images were taken every 20 minutes. For each time
point, images of different Z sections were overlaid to produce
single extended-focus image.For each time point, images of
different Z sections were overlaid to produce single extended-
focus image.
Found at: doi:10.1371/journal.pone.0006551.s002 (6.62 MB
MOV)
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